Health & bio

FDA Approves AUVELITY for Alzheimer's Agitation on April 30

AXS-05 (bupropion/dextromethorphan) approved for Alzheimer's dementia-related agitation indication.

Primary sources · 1
FDA
← View the full 2026-05-02 (Sat) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →